BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24382701)

  • 1. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.
    Corral R; Lewinger JP; Van Den Berg D; Joshi AD; Yuan JM; Gago-Dominguez M; Cortessis VK; Pike MC; Conti DV; Thomas DC; Edlund CK; Gao YT; Xiang YB; Zhang W; Su YC; Stern MC
    Int J Cancer; 2014 Jul; 135(2):335-47. PubMed ID: 24382701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in the base excision repair pathway and bladder cancer risk.
    Figueroa JD; Malats N; Real FX; Silverman D; Kogevinas M; Chanock S; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Rothman N; García-Closas M
    Hum Genet; 2007 Apr; 121(2):233-42. PubMed ID: 17203305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.
    Stern MC; Van Den Berg D; Yuan JM; Conti DV; Gago-Dominguez M; Pike MC; Xiang YB; Gao YT; Cortessis VK
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3057-61. PubMed ID: 19843673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk.
    García-Closas M; Malats N; Real FX; Welch R; Kogevinas M; Chatterjee N; Pfeiffer R; Silverman D; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; Chanock S; Yeager M; Rothman N
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):536-42. PubMed ID: 16537713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
    Stern MC; Lin J; Figueroa JD; Kelsey KT; Kiltie AE; Yuan JM; Matullo G; Fletcher T; Benhamou S; Taylor JA; Placidi D; Zhang ZF; Steineck G; Rothman N; Kogevinas M; Silverman D; Malats N; Chanock S; Wu X; Karagas MR; Andrew AS; Nelson HH; Bishop DT; Sak SC; Choudhury A; Barrett JH; Elliot F; Corral R; Joshi AD; Gago-Dominguez M; Cortessis VK; Xiang YB; Gao YT; Vineis P; Sacerdote C; Guarrera S; Polidoro S; Allione A; Gurzau E; Koppova K; Kumar R; Rudnai P; Porru S; Carta A; Campagna M; Arici C; Park SS; Garcia-Closas M;
    Cancer Res; 2009 Sep; 69(17):6857-64. PubMed ID: 19706757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.
    Wen H; Ding Q; Fang ZJ; Xia GW; Fang J
    Int Urol Nephrol; 2009 Dec; 41(4):855-64. PubMed ID: 19350405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
    Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
    Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M
    Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair gene XRCC1 polymorphisms and bladder cancer risk.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    BMC Genet; 2007 Apr; 8():13. PubMed ID: 17425776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.
    Wu X; Gu J; Grossman HB; Amos CI; Etzel C; Huang M; Zhang Q; Millikan RE; Lerner S; Dinney CP; Spitz MR
    Am J Hum Genet; 2006 Mar; 78(3):464-79. PubMed ID: 16465622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study.
    Roberts MR; Shields PG; Ambrosone CB; Nie J; Marian C; Krishnan SS; Goerlitz DS; Modali R; Seddon M; Lehman T; Amend KL; Trevisan M; Edge SB; Freudenheim JL
    Carcinogenesis; 2011 Aug; 32(8):1223-30. PubMed ID: 21622940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
    Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
    Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility.
    Huang M; Dinney CP; Lin X; Lin J; Grossman HB; Wu X
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):84-91. PubMed ID: 17220334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers.
    Wen H; Feng CC; Fang ZJ; Xia GW; Jiang HW; Xu G; Huang XD; Ding Q
    Actas Urol Esp; 2013 May; 37(5):259-65. PubMed ID: 23246108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
    Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated NER expressions of XPF and XPC associated with smoking are involved in the recurrence of bladder cancer.
    Qiu J; Wang X; Meng X; Zheng Y; Li G; Ma J; Ye G; Li Y; Li J
    PLoS One; 2014; 9(12):e115224. PubMed ID: 25535740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2537-41. PubMed ID: 17164382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.
    Ramaniuk VP; Nikitchenko NV; Savina NV; Kuzhir TD; Rolevich AI; Krasny SA; Sushinsky VE; Goncharova RI
    Biomarkers; 2014 Sep; 19(6):509-16. PubMed ID: 25089939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.